Kangmei Pharmaceutical Co Ltd - Company Profile
Powered by
All the data and insights you need on Kangmei Pharmaceutical Co Ltd in one report.
- Save hours of research time and resources with
our up-to-date Kangmei Pharmaceutical Co Ltd Strategy Report
- Understand Kangmei Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Kangmei Pharmaceutical Co Ltd (Kangmei) is a manufacturer and distributor of herbal medicine. The company provides herbal raw materials and preparations. Its products include Chinese herbal medicine, bottled single product and chemical drugs, among others. Kangmei provides chemical drugs such as clarithromycin dispersible tablets, doxazosin mesylate tablets, propiverine hydrochloride tablets, and paracetamol and pseudoephedrine hydrochloride tablets. The company also offers Xinkaihe warm tea, Ginkgo thirty-seven hawthorn polyphenol capsules, Propolis, McKinley card Calcium Iron zinc and selenium chewable tablets and Happiness red Luzhou nourishing Okuma. Kangmei is headquartered in Shenzhen, Guangdong, China.
Kangmei Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
Products |
---|
Chinese Herbal Medicine |
Bottled Single Product |
Participation Xinkaihe |
XYZ |
XYZ |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Contracts/Agreements | In October, the company signed a cooperation agreement with Kangmei Pharmaceutical to make changes in close linkage and efficient docking. |
2023 | Contracts/Agreements | In March, the company entered into a partnership with PSM Puning City to conduct free clinics and drug safety science popularization activities. |
2022 | Contracts/Agreements | In June, the company entered into an agreement with Dingxi Municipal People’s Government to improve the influence of the National Traditional Chinese Medicine Expo platform. |
Competitor Comparison
Key Parameters | Kangmei Pharmaceutical Co Ltd | China National Accord Medicines Corporation Ltd | Tasly Pharmaceutical Group Co Ltd | Zhejiang Conba Pharmaceutical Co Ltd | Jiangsu Nhwa Pharmaceutical Co Ltd |
---|---|---|---|---|---|
Headquarters | China | China | China | China | China |
City | Shenzhen | Shenzhen | Tianjin | Hangzhou | Xuzhou |
State/Province | Guangdong | Guangdong | Tianjin | Zhejiang | Jiangsu |
No. of Employees | 6,371 | 39,296 | 9,183 | 8,415 | 4,955 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Lai Zhijian | Chairman | Executive Board | 2022 | 54 |
Liu Guowei | Managing Director | Executive Board | 2020 | 50 |
Gong Guibo | Deputy General Manager; Chief Financial Officer | Senior Management | 2020 | 49 |
Liu Xinquan | Deputy General Manager | Senior Management | 2022 | 49 |
He Zezheng | Deputy General Manager | Senior Management | 2021 | 46 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward